DRUG

Isoginkgetin

2 hypotheses across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for Isoginkgetin

Alzheimer 2

Mediator Outcome Score Tier Lit. status Trial
GSK-3β Alzheimer's disease 0.220 Mid partial evidence none
GSK-3β tau hyperphosphorylation 0.220 Mid novel signal none

Clinical trials

0 registered trials for Isoginkgetin

Source: ClinicalTrials.gov

No registered trials found on ClinicalTrials.gov. This could indicate either an unexplored indication or a gap in registry coverage.

Search ClinicalTrials.gov →